Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11171940 | 0.86 | PIN1 (0.49) | LMNAALDH1A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL26325985 | 0.85 | LMNA (0.51) | LMNAALDH1A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL4081281 | 0.84 | TSHR (0.47) | LMNAALDH1A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL26327664 | 0.78 | LMNA (0.45) | LMNAALDH1A1SMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL26327797 | 0.78 | LMNA (0.45) | LMNAALDH1A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL26327819 | 0.78 | LMNA (0.45) | LMNAALDH1A1SMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL26327800 | 0.78 | LMNA (0.45) | LMNAALDH1A1SMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL26327651 | 0.77 | LMNA (0.44) | LMNAALDH1A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL26327977 | 0.76 | LMNA (0.46) | LMNAALDH1A1SMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL25439821 | 0.76 | TSHR (0.43) | LMNAALDH1A1CHRNB2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | WILLIAM MARSH RICE UNIVERSITY (US) | 2023-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | PNMT, NCL, NPM1 | LMNA 167/4885ALDH1A1 1805/4885CHRNB2 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.